VISION IN THE FUTURE

News

Re-Vana Therapeutics Secure Innovate UK Grant

by | Oct 15, 2019 | News | 0 comments

Re-Vana has developed a novel disruptive photocrosslinked proprietary biodegradable sustained release drug delivery implant, EyeLief. The implant will provide significant clinical benefits over current monthly intravitreal injections. Following injection into the eye, the implant would provide a continuous release for effective AMD treatment over a 4-6 months period. 

Read more >

Do NOT follow this link or you will be banned from the site!